Skip to main content

Latest News

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS
ALXAAMRNBIIB

28 Drugs Facing FDA Approval in 2012-2013

By Adam Feuerstein
Jul 24, 2012 7:38 AM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS
AFFYCHTPMAPP

Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest

By Adam Feuerstein
Mar 23, 2012 5:30 AM EDT
ASCO 2012 Live Blog -- Saturday
INVESTING
TLON

Talon Therapeutics: FDA Panel Live Blog

By Adam Feuerstein
Mar 21, 2012 7:54 AM EDT
Vertex Pharma Cystic Fibrosis FDA Advisory Panel Live Blog
INVESTING
AFFYARIACHTP

Biotech Stock Chat: Recap

By Adam Feuerstein
Mar 15, 2012 11:54 AM EDT
MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
STOCKS
SNYTLON

Talon: Assessing Marqibo's FDA Odds

By Adam Feuerstein
Mar 13, 2012 10:02 AM EDT

Recommended for You

TECHNOLOGY

Elon Musk Thinks of Buying Twitter at a Lower Price

By Luc Olinga
JIM CRAMER

Cramer's Mad Money Recap 5/16: McDonald's, JetBlue, Twitter

By Scott Rutt
INVESTING

Michael 'Big Short' Burry Shorts Apple

By Ellen Chang
PRESS RELEASES

Lost Money In NeoGenomics, Inc.?

By Business Wire